AlphaMark Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

AlphaMark Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,089	Closed	-$11K	–	573
2020 Q2	$11K	Buy	12,089 +3,150	+35%	+$3K	﹤0.01%	357
2020 Q1	$7K	Buy	8,939 +1,739	+24%	+$2.02K	﹤0.01%	352
2019 Q4	$7K	Buy	7,200 +3,000	+71%	+$3.29K	﹤0.01%	378
2019 Q3	$4K	Buy	4,200 +1,000	+31%	+$1.36K	﹤0.01%	424
2019 Q2	$6K	Hold	3,200	–	–	﹤0.01%	401
2019 Q1	$6K	Buy	+3,200	New	+$4.68K	﹤0.01%	387

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AlphaMark Advisors's INFI Position: Q3 2020 in Review

AlphaMark Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2020, closing a stake of 12,089 shares — an estimated $11K sold.

AlphaMark Advisors first reported a position in INFI in Q1 2019 and held it in 6 quarters. The position peaked at $11K in Q2 2020. 45 funds tracked by Wall St. Rank hold INFI as of Q3 2020.

AlphaMark Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
AlphaMark Advisors sold 12,089 Infinity Pharmaceuticals, Inc. shares in Q3 2020, an estimated $11K.
AlphaMark Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2019 and held it in 6 quarters.
AlphaMark Advisors's Infinity Pharmaceuticals, Inc. position peaked at $11K in Q2 2020.
45 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2020.

Based on AlphaMark Advisors's 13F filing for Q3 2020, filed 6 Nov 2020.